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Abstract 
PEGylated polymer capsules encapsulating LaVO4:Tb
3+
, GdVO4:Tb
3+
, Gd2O3:Tb
3+
, GdF3:Tb
3+
, 
YVO4:Tb
3+ 
and iron oxide nanoparticles are promising new fluorescence, magnetic and 
magnetofluorescence imaging agents. Recently, we have reported the in vitro and in vivo level 
toxicity profile which shows the non-toxic nature of polymer capsules encapsulating 
nanoparticles. However, prior to clinical use, it is essential to ensure that these agents are 
unlikely to activate immune responses. Herein, we investigated the immuno-compatibility of 
polymer capsules with dendritic cells (DC) and macrophages (MO), major antigen presenting 
cell (APC) subsets required for activation of innate and adaptive immunity.  Capsules were 
efficiently internalized by both DC and MO in vitro. Importantly, despite the presence of 
intracellular capsules, there was no significant impact on the viability of cells. We studied the 
impact of different capsules on the cytokine profile of DC and MO, known to be important for 
the polarization of T-cell immunity.  None of the capsules elicited change in cytokine secretion 
from DC. Furthermore, capsules did not alter the polarization of either M1 or M2 MO subsets as 
determined by the balance of IL-12 and IL-10 secretion. These data support the notion that 
PEGylated polymer capsules loaded with nanoparticles have the potential to remain 
immunologically silent as they do not activate APC and neither do they hinder the response of 
DC or MO to pathogen activating signals. These systems, therefore, exhibit promising 
characteristics for bioimaging applications. 
KEYWORDS: PEGylated polymer capsules, M1 and M2 macrophages, dendritic cells, immune 
response 
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1.Introduction 
The development of nanobioimaging agents possessing enhanced contrast, immunocompatibility, 
biocompatibility, increased circulation time in blood and proper clearance from body is a 
propelling research area of nanomedicine. Recently, various nanocontrast agents (e.g. gold, 
superparamagnetic iron oxide, gadolinium-based nanoparticle) including multimodal imaging 
agents (e.g. magentofluorescence, X-ray contrast agent with fluorescence meoity/MRI ability) 
are being explored for bioimaging applications to obtain precise information from the target site. 
In order to apply these materials at the clinical phase, they should be investigated for following 
important biological studies: in vitro toxicity,
1
 in vivo  biodistribution/toxicity
2-4
 and immune-
toxicity.
5
 Though most of the nanocontrast agents have been tested for in vitro cytotoxicity and 
to some extent, in vivo biodistribution, their immunogenicity studies are either rarely explored or 
they possess immnuotoxicity.  We note that there are some reports available on the investigation 
of generation of reactive oxygen species (ROS) which is also an indicator of immune toxicity.
6
 
In summary, it is vital to explore the immune response of nanoparticles along with in vitro and in 
vivo toxicity studies. 
Immune responses from the body are one of the complex biological mechanisms 
comprising of diverse signaling pathways. Once a foreign object (e.g. nanocontrast agents) enters 
the body, it is recognized as “non-self” by antigen presenting cells (APCs), such as macrophages 
and dendritic cells which trigger immune responses. Thus, it is essential to understand the 
immune response of newly developed nanocontrast agent, in addition to in vitro and in vivo tests. 
Two types of immune responses-innate and adaptive immunity are generated in our body by 
immune cells. Innate immunity is non-specific which is produced by cells including dendritic 
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cells, macrophages, natural killer cells, granulocytes (basophils, neutrophils, eosinophils), mast 
cells etc. whereas, adaptive immunity is highly specific which is produced by B and T cells. The 
APC constantly travel through the tissues scavenging for antigens such as bacteria, viruses or 
foreign bodies.
7
 Upon antigen recognition APC starts secreting cytokines and travel to regional 
lymph node in order to activate T cell responses. In addition to activating T-cells, APC polarize 
their responses towards inflammation for example, through secretion of IL-12 which stimulate 
the generation of Th1 or tolerance through secretion of IL-10 which promote regulatory T-cells 
induction (Treg).
8-12
 Therefore, various cytokines (for example, IL-12, IL-10, IL-6, IL-23 etc.) 
secreted by the APCs alert other cells of adaptive immunity in defense system for triggering 
specific immune response, for entry of foreign particle thereby creating a complete cluster of 
defense. Since, cytokines are the primary molecules of immune response, the evaluation of 
cytokine levels are used as biomarkers for understanding immune modulation by 
nanomaterials.
13-15
Herein, we investigate immunological response of set of nanoparticles by 
monitoring cytokines secreted by APCs. In this regard, we investigated the response of healthy 
human monocyte derived dendritic cells (immature, mature) and macrophages (M1, M2) to novel 
candidate capsules containing a range of contrast agents. 
Recently, we developed LaVO4:Tb
3+
, YVO4:Tb
3+
, GdVO4:Tb
3+
, Gd2O3:Tb
3+
, GdF3:Tb
3+ 
and iron oxide nanoparticles encapsulated polymer capsules for bioimaging applications.
16
 These 
nanoparticles-encapsulated polymer capsules possess the following advantages: (a) 
biocompatibility, (b) various nanoparticles can be encapsulated via single approach, (c) targeted 
delivery of nanoparticles by antibody modification of capsules, (d) can be converted into 
theranostic vehicle by incorporation of drug molecules, and (e) single internalization mechanism 
of nanoparticles  in different cells, (f) LaVO4:Tb
3+
 and YVO4:Tb
3+ 
nanoparticles exhibit 
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fluorescence for optical imaging
17, 18
 whereas iron oxide can be employed for magnetic 
resonance (MR) imaging, (g) GdVO4:Tb
3+
, Gd2O3:Tb
3+
, and GdF3:Tb
3+
 have been found to 
display both fluorescence (optical imaging) and  MR imaging.
19, 20
In our recent reports, these 
polymer capsules encapsulating nanoparticles were demonstrated as biocompatible at both in 
vitro at in vivo levels.
16, 21
Since, they possess good imaging properties along with 
biocompatibility and efficient internalization, it is essential to study their immune response. 
For this study, we have chosen macrophages (M1 and M2) and dendritic cells (mature 
and immature) derived from human blood of different donors. Enzyme linked immunosorbent 
assay (ELISA) has been carried out for detection of interleukins IL-10 and IL-12 which were 
marked to assess the onset of immune responses by APCs. We found that polymer capsules 
encapsulating nanoparticles are immune-silent as they neither increase (immune-stimulator) nor 
decrease (immune-suppressor) the levels of interleukins (biomarkers of APCs).  
2. Materials and methods 
2.1. Materials 
Gadolinium nitrate hydrate (Gd(NO3)3.xH2O) was prepared by nitrification of gadolinium 
oxide(Gd2O3), terbium (III) nitrate pentahydrate (Tb(NO3)3.5H2O), yttrium nitrate tetrahydrate 
(Y(NO3)3.4H2O), lanthanum nitrate hydrate (LaNO3.xH2O), polyethylene glycol (Mw. 10,000), 
poly(sodium 4-styrene-sulfonate) (Mw. 70,000), poly(allylamine hydrochloride) (Mw.56,000), 
bisamine (polyethylene glycol) Mw. 6,000, tetraethyl orthosilicate (TEOS), rhodamine B 
isothiocyante were purchased from Sigma-Aldrich with all the lanthanide salts of 99.9% purity 
and used without further purification. Polyethylene imine (PEI, Mw.70000 branched), Alfa 
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Aesar, citric acid (Qualigens), liquor ammonia (about 24%), hydrofluoric acid (40%w/v), Merck; 
ammonium fluoride, sodium metavanadate (NaVO3) from Lobachemie. 
Buffy coats were obtained from National Blood Transfusion Service, whilst CD14+ monocyte 
isolation kit was obtained from Miltenyi Biotec. Histopaque 1.077, and RPMI were obtained 
from Sigma Aldrich. For cell uptake experiments, RITC-phalloidin, fluorescein isothiocyante 
(FITC) and fluorshield DAPI were obtained from Sigma Aldrich. 
Dulbecco’s modified eagle’s medium (DMEM), trypsin- EDTA, penicillin-streptomycin 
antibiotic, (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT), were obtained 
from Sigma Aldrich and used without further purification. Fetal bovine serum was purchased 
from Gibco® and Cy 5.0 CellMask™ deep red plasma membrane stain (ex 649nm/em 666nm) 
was purchased from Invitrogen, India. Dimethylsulfoxide (DMSO) and formaldehyde were 
obtained from Merck Chemicals, India. rhGM-CSF was obtained from Peprotech  (Rocky Hill, 
NJ,USA); rh M-CSF from ImmunoTools (Firesoythe, Germany); rhIL-4 and IFN-γ from R&D 
Systems Europe (Oxford, United Kingdom); Ultrapure LPS (Salmonella Minnesota LPS) was 
from InvivoGen (San Diego, CA,USA). Ultra-low attachment plates (Corning, NY, USA) 
2.2. Generation of dendritic cells and macrophages 
PBMCs were isolated from Buffy coats with Histopaque 1.077 by gradient centrifugation. 
CD14+ve monocytes were purified with anti-CD14 magnetic beads (Miltenyi). Monocyte derived 
DCs were generated as previously described.
22, 23
 Briefly, positively selected CD14+ monocytes 
were cultured in DC medium (RPMI, 10%FBS, 1% sodium pyruvate) containing rhGM-CSF and 
rhIL-4 (both 1000 U/mL). Additional complete medium with cytokines was added on day 3-4.
24
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Macrophages were generated from CD14+ve cells by culture in ultra-low attachment plates for 5-6 
days in complete medium (RPMI, 10% FBS, 1% sodium pyruvate) with 20 U/mL GM-CSF for 
generation of M1 or 10 ng/mL M-CSF for generation of M2 phenotype. Additional complete 
medium with cytokines was added on day 4. The phenotype of cells was confirmed by flow 
cytometry and profiling of cytokines released on maturation.  DC and M1 MO were activated with 
LPS (500 ng/mL) and IFN-γ 1000 U/mL) for 24h, M2 macrophages were activated with LPS (500 
ng/mL) alone.  
2.3. Cell uptake and MTT assay studies. For observing the internalization of polymer capsules, 
both mature DCs were seeded on sterile coverslips (50,000 cells per well) placed on 6-well plate.  
The capsules (25 capsules per cell) were incubated for 5 h with PEGylated PSS/PAH capsules 
encapsulating LaVO4:Tb
3+
, YVO4:Tb
3+
, GdVO4:Tb
3+
, Gd2O3:Tb
3+
, GdF3:Tb
3+ 
and iron oxide 
nanoparticles (synthesis procedure of polymer encapsulated nanoparticles are provided in 
supplementary information). The wells were washed with PBS to remove unbound capsules. The 
cells were fixed with formaldehyde (2%) for 20 min followed by washing twice with PBS. 
Coverslips were mounted on slides in Fluorshield DAPI to stain the nucleus. For cell uptake in IC-
21 macrophages (mouse peritoneal cells), 10
5 
capsules were seeded and rested overnight. Capsules 
(25 capsules per cell) were added to cells and incubated for 5 h. Unbound capsules were removed 
by washing twice with PBS prior to fixing with formaldehyde. Cell membranes were stained using 
deep red membrane dye (Cy5). MTT assay for quantifying cell viability was also carried out in 
same conditions as cell uptake studies.
25
 UV-visible absorbance was recorded at 570 nm.  
2.4. DC and MO phenotyping 
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Flow cytometry was performed on MACS Quant flow cytometer (Miltenyi). For extracellular 
staining cells were stained with HLA-DR FITC, CD80 APC, CD86 Vio-blue (all Miltenyi), 
CD40 FITC, CD83 PE (BD Biosciences) for 30 min on ice. For CD68, cells were fixed and 
permeabilised using Inside Stain Kit (Miltenyi) and stained with CD68 FITC (Miltenyi). Flow 
cytometry experiments were analyzed in FlowJo software.  
2.5. ELISA assay for quantification of cytokine levels 
Immature DCs were seeded at 50,000 cells/well in DC media (RPMI 1640, 10% FCS, sodium 
pyruvate) and rested for 2 h. DCs were incubated with PEGylated polymer capsules 
encapsulating LaVO4:Tb
3+
, YVO4:Tb
3+
, GdVO4:Tb
3+
, Gd2O3:Tb
3+
, GdF3:Tb
3+ 
and iron oxide 
nanoparticles (25 capsules per cell) for 24 h. In order to get mature DCs, LPS/IFN-γ was added 
and incubated for 2 h. A similar protocol was followed for M1 and M2 macrophages. The 
secretion of IL12p70 and IL10 was performed by commercial human ELISA kit (eBioscience 
and R&D Duoset respectively). The sensitivity of IL-12p70 ELISA was 7.8 pg/mL and IL-10 
was 31.2 pg/mL. Absorbance was read at 450 nm wavelengths using a spectrometer. 
2.6. Characterizations 
The morphology of the samples was acquired from SUPRA
®
 Series Ultra High Resolution Field 
Emission-Scanning Electron Microscope FE-SEM (SEM). The formation of core-shell structure 
was visualized from Transmission Electron Microscope (TEM) images obtained using FEI 
Technai Twin microscope with high contrast and resolution at 20kV to 120kV. Internalization of 
polymer capsules in cells has been confirmed through images from laser scanning confocal 
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microscope Carl Zeiss LSM 710 and LSM 810.UV-visible absorbance was recorded for MTT 
assay using Thermoscientific UV-Visible spectrophotometer. 
2.7. Statistics 
Statistical analysis was undertaken using Graphpad prism 5.0. ELISA assay data were plotted 
using mean ± SD and statistical significance determined with two-tailed t-test. In case of 
multiple data comparison, data is analyzed using one-way ANOVA test followed by Bonferroni 
post-test. 
3. Results  
3.1. Characteristics of nanoparticle-loaded capsules 
Silica particles (~500 nm) were fabricated by modified Stöber’s process.
26, 27
Lanthanide doped 
nanoparticles were coated over silica using a method adapted by Yu et al.
28
 Synthesis of 
GdF3:Tb
3+ 
and iron oxide nanoparticles were carried out using PEGylated polymer capsules as 
microreactor.
25, 29
The formation of polymer capsules encapsulating LaVO4:Tb
3+
, GdVO4:Tb
3+
, 
Gd2O3:Tb
3+
, GdF3:Tb
3+
, YVO4:Tb
3+
 and iron oxide nanoparticles have been confirmed by 
performing transmission electron microscopy (TEM). TEM images (Figure 1) show contrast 
difference between polymer capsules and nanoparticles (size: ~45 nm) confirming the 
entrapment of nanoparticles inside capsules.
16
 HRTEM images display lattice fringes showing 
crystalline nature of material.   
3.2. Interaction of capsules with DC and MO 
Page 10 of 24Journal of Materials Chemistry B
Jo
ur
na
lo
fM
at
er
ia
ls
C
he
m
is
tr
y
B
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
26
 M
ay
 2
01
7.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f N
ot
tin
gh
am
 o
n 
30
/0
5/
20
17
 1
5:
49
:1
7.
 
View Article Online
DOI: 10.1039/C7TB01044C
10 
 
Internalization of capsules was studied in DC, followed by quantification of interleukins to 
understand behavior of APCs on interaction with polymer capsules. In the case of cell uptake 
studies, CLSM images Figure 2 shows PEGylated polymer capsules internalized by DCs after 5 
h incubation time. The internalization is confirmed by green emission arising from terbium ions 
(λex=488 nm) doped in LaVO4/GdVO4/Gd2O3/GdF3/YVO4 nanoparticles and red emission from 
RITC-labeled PAH layer of capsules loaded with iron oxide. Since the number of macrophages 
obtained from human blood was insufficient for cell uptake and cytotoxicity assays, a peritoneal 
macrophages cell line (IC-21, murine) was substituted. Figure 3 represents internalization of 
polymer capsules encapsulating nanoparticles in IC-21 cells (revealed by green emission from 
terbium ions/FITC labeled PAH layer). Capsules were not observed to adversely impact the 
viability of any cells studied. Figure S1 represents MTT assay plot exhibiting biocompatibility of 
capsules with macrophages.  
3.3. Capsules do not activate resting DC nor perturb DC activation 
The purity and quality of generated DC was assessed by phenotypic analysis. In agreement with 
previous reports DC generated from CD14+ve monocytes in the presence of GM-CSF and IL-4 
showed loss of CD14 expression, high HLA-DR and were positive for CD80, CD40, CD86 
while CD83 expression was negative.
22, 23
Upon activation with LPS/IFN-γ for 24 h DC 
demonstrated typical signs of maturation by increase in HLA-DR, CD80, CD40, CD86 and gain 
of CD83 (Figure S2a,b).
30-34
 
Resting DC and MO are very sensitive to a wide range of signals that indicate the presence of 
potential pathogens or damaged tissues. Therefore, novel imaging reagents would ideally not 
result in activation of resting APC.  In order to test this, resting cells were exposed to capsules 
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and their release of cytokines determined.  Immature DC produced very little IL-10 and no IL-
12. Upon exposure to LPS, mature DC (mDC) secreted markedly increased levels of both 
cytokines.  Incubation of APCs with polymer capsules encapsulating LaVO4, GdVO4, Gd2O3, 
iron oxide and YVO4 nanoparticles did not significantly modulate cytokine production from 
immature DC (Figure 4).Upon activation through pathogen receptors (e.g. TLR4), DC produce 
an array of cytokines that are involved in the polarization of subsequent immune responses. 
Therefore, we tested the impact of capsules on the maturation response of DC to the TLR4-
agonist, LPS. The secretion of IL-12 and IL-10 by matured DC was not affected by the addition 
of nanoparticle-loaded capsules. 
3.4. Capsules do not alter the polarization of M1 or M2 macrophages 
Macrophages are broadly classified into M1 and M2 type based on their phenotype and cytokine 
expression. M1 was confirmed by positive staining with CD68. Both M1 and M2 macrophages 
expressed HLA-DR, CD86 and CD80 which increased upon activation. Expression of HLA-DR 
and CD86 was greater in resting and activated M1 compared to M2 macrophages. CD83 and 
CD40 were absent on immature and mature M2 but whilst absent on immature M1 they were 
expressed by mature M1 (Figure S3a,b).
30, 34
 
Mature M1 macrophages produced high levels on IL-12 and low IL-10 while mature M2 
macrophages preferentially secreted IL-10 whereas IL-12 levels were low. M1 macrophages 
incubated with polymer capsules encapsulating nanoparticles expressed similar levels of IL-12 
and IL-10 after LPS activation compared to control (only cells) indicating that they are not 
altering the immune response of cells (Figures 5a and c). Similarly, M2 incubated with polymer 
capsules do not show altered expression levels of IL10 and IL-12 comparable to control (only 
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cells) indicating immune compatibility of polymer capsules encapsulating nanoparticles (Figures 
5c and d) in all.  
4. Discussion 
Synthesis of PEGylated polymer capsules encapsulating YVO4/GdVO4/LaVO4/Gd2O3:Ln
3+ 
nanoparticles  involves following steps: (a) fabrication of YVO4/GdVO4/LaVO4/Gd2O3:Ln
3+
 
shell over silica to form a core-shell structure by sol-gel method, (b) deposition of  PSS/PAH 
polyelectrolytes (LbL assembly) on core-shell particles, (c) PEGylation (stealth coating),
35
 and 
(d) removal of silica core using buffer oxide etchant leading to formation of PEGylated polymer 
capsules encapsulating nanoparticles.  
The polymer capsules were tested for its immunocompatibility by tracking the changes in 
interlukin secretions by APCs. Interleukins are also an indicator of reactive oxygen species 
(ROS) generation which leads to organ damage via inflammation.
6
 Hanley et al. have reported 
ZnO nanoparticles-induced enhanced secretion of proinflammatory cytokines in polymorphic 
blood mononuclear cells (PBMCs) and monocytes.
36
 In another report, gadolinium nanoparticles 
were found to exhibit minimal immunotoxicity which was also quantified by interleukin 
secretions from blood serum.
37
 
We have demonstrated the in vitro biocompatibility and efficient internalization of PEGylated 
polymer capsules encapsulating nanoparticles in 7 different cell lines including HeLa, MCF-7, 
H460, A498, L929, Schwann cells and IC-21 MO. In addition, herein we have investigated the 
immunocompatibility of polymer capsules with human blood derived dendritic cells and 
macrophages. Dendritic cells were isolated from PBMCs as immature cells. Lipopolysaccharide 
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(LPS), a major TLR-4 (Toll-like receptor) agonist was added to iDCs for artificially maturating 
them.
38
 Upon maturation, DC secrete cytokines including IL-10 and 12 that modulate the 
activation of T-cells during their activation by DC. Our study focused on IL-12 and IL-10 for 
their role in Th1 and Th2/Treg responses respectively. PEGylated polymer capsules had no 
impact on IL-10 or IL-12 secretion (Figure 4).  
Though in most of the reports, cytokine secretion has been studied in DC, it is equally important 
to explore it in macrophages as IL-10 and IL-12 secreted by them also influences immune 
response. Macrophages are classified as M1 (anti-tumor) and M2 (pro tumor) in which M1 
suppresses tumor activity, promote Th1 responses whereas, M2 promote tumor growth through 
angiogenesis and anti-inflammatory effects.
12
M1 macrophages expressed higher levels of IL-12, 
in contrast to M2 macrophages which expressed higher levels of IL-10, though slight decrease in 
IL levels were observed with GdF3 -loaded capsules which can be attributed to presence of Gd
3+ 
ions on the surface of capsules.  
It should be borne in mind that our study focused on the early events in terms of activation of 
antigen presenting cells.  Future studies should address the potential for delayed immune events 
or indeed consequences that arise from repeated exposure to the capsules.  Such events may 
include altered homing to draining lymph nodes, cross-presentation of antigens, or complex 
changes in gene expression. The silent nature of the tested capsules may mean it would be 
interesting to also investigate any impact on immune tolerance. 
In summary, the present study demonstrated the immunological silence of the tested polymer 
capsules in both resting and activated DC and macrophages making them promising candidates 
for further work. IL-10 and IL-12 cytokine responses are very sensitive to confounding factors 
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that activate or inhibit the function of these cells. Future studies will examine the effect of 
polymer capsules on specialized advanced functions of DC and MO including chemotaxis, 
antigen-presentation and cross-presentation.   
5. Conclusions 
PEGylated polymer capsules encapsulating LaVO4:Tb
3+
, GdVO4:Tb
3+
, Gd2O3:Tb
3+
, GdF3:Tb
3+
 
iron oxide nanoparticles were studied for their immune responses in dendritic cells (mature and 
immature) and macrophages (M1and M2). From cell uptake studies in dendritic cells and 
macrophages, it has been observed that capsules were internalized in the cells. ELISA assay 
performed to measure interleukins IL-10 and IL-12 levels, indicates comparable levels of 
secretion with the control. The capsules encapsulating nanoparticles are neither involved in 
immuosuppression or inflammatory response. The results conclude that PEGylated polymer 
capsules are not inducing any immune response confirming their safe applicability as bioimaging 
agents. 
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Figure 1. TEM images of PEGylated polymer capsules encapsulating: (a) LaVO4:Tb
3+
, (b) 
YVO4:Tb
3+
, (c) GdF3:Tb
3+
, (d) GdVO4:Tb
3+
, (e) iron oxide and (f) Gd2O3:Tb
3+
 nanoparticles 
(Inset: HR-TEM images showing lattice fringes of respective nanoparticles). 
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Figure 2. Confocal laser scanning microscopy images showing internalization of PEGylated 
polymer capsules encapsulating Gd2O3:Tb
3+
, GdVO4:Tb
3+
, GdF3:Tb
3+ 
and iron oxide 
nanoparticles in mature dendritic cells (scale bar = 20 µm). 
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Figure 3. CLSM images showing internalization of PEGylated polymer capsules encapsulating 
nanoparticles in IC-21 cell line (mouse peritoneal macrophages): (a) LaVO4:Tb
3+
, (b) 
YVO4:Tb
3+
, (c) iron oxide (capsules labeled with FITC), (d) GdVO4:Tb
3+
, (e) Gd2O3:Tb
3+
 and 
GdF3:Tb
3+
(scale bar = 20 µm). 
(a) (b) (c) 
(f) (e) (d) 
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Figure 4. ELISA assay plots of PEGylated polymer capsules encapsulating nanoparticles in 
immature and mature dendritic cells for detecting (a,b) IL-12 secretion (in pg/ml) and (c,d) IL-10 
(in pg/ml) of  four donors(*** signifies p<0.0001, ** signifies p<0.005). 
 
 
 
 
 
 
 
Figure 5. ELISA assay plots of PEGylated polymer capsules encapsulating nanoparticles in M1 
and M2 macrophages for detecting (a,b) IL-12 secretion (in pg/ml) and (c,d) IL-10 (in pg/ml) of 
four donors (*** signifies p<0.0001, ** signifies p<0.005). 
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